TESARO (TSRO)- Jeffrey H. Hanke, Executive VP, R&D and CSO, sold 12,500 shares at $74.35. The total value of the transaction was $929,321. Hanke does not own any shares of TSRO.
Ophthotech (OPHT)- Samir Chandrakant Patel, President, sold 41,846 shares in two separate transactions. Patel sold 20,000 shares at $51.42; and 21,846 shares at $51.05. Patel still owns 191,531 shares of OPHT.
Oragenics (OGEN)- Koski Family, LP, a 10% owner, bought 5,815,080 shares of OGEN at $0.52. Koski Family now owns 12,864,822 shares of OGEN. Fred Telling, Director, bought 969,180 shares of OGEN at $0.52. Telling now owns 1,315,354 shares of OGEN.
Repligen (RGEN)- Thomas F. Ryan Jr., Director, sold 5,000 shares at $26.60. The total value of the transaction was $133,010. Ryan still owns 12,094 shares of RGEN.
United Therapeutics (UTHR)- Martine A. Rothblatt, Chairman & CEO, sold 1,308 shares of $105.10. The total value of the transaction was $137,470. Rothblatt still owns 240 shares of UTHR.
Merck & Co. (MRK)- Adam H. Schechter, EVP & President-Global Human Health, sold 50,000 shares at $57.69. Schechter does not own any shares of MRK. Weir Mirian Graddick, Exe-VP, HR, sold 30,000 shares at $57.49. Graddick still owns 132,151 shares of MRK.